Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
C$1.32
+5.6%
C$1.32
C$0.80
C$4.06
C$256.62MN/A1.51 million shs310,601 shs
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
$0.00
$0.00
$0.00
N/AN/A11,650 shsN/A
Almirall, S.A. stock logo
LBTSF
Almirall
$13.36
$9.62
$9.01
$13.36
N/AN/A200 shsN/A
Valaris Limited stock logo
VAL
Valaris
$45.44
+0.0%
$40.27
$27.15
$84.20
$3.23B1.151.61 million shs699,369 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
0.00%0.00%0.00%0.00%0.00%
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00%0.00%0.00%0.00%+∞
Almirall, S.A. stock logo
LBTSF
Almirall
0.00%0.00%+48.28%+48.28%+40.48%
Valaris Limited stock logo
VAL
Valaris
0.00%+8.36%+15.26%+54.07%-38.37%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/AN/AN/AN/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
1.9886 of 5 stars
1.91.00.00.01.41.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
0.00
N/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
0.00
N/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
0.00
N/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
1.86
Reduce$51.6713.70% Upside

Current Analyst Ratings Breakdown

Latest VAL, ATTBF, ABCN, ABZA, and LBTSF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/1/2025
Valaris Limited stock logo
VAL
Valaris
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$40.00 ➝ $46.00
6/18/2025
Valaris Limited stock logo
VAL
Valaris
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$44.00 ➝ $47.00
5/5/2025
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$35.00 ➝ $37.00
5/2/2025
Valaris Limited stock logo
VAL
Valaris
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$55.00 ➝ $50.00
4/14/2025
Valaris Limited stock logo
VAL
Valaris
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$47.00 ➝ $34.00
4/7/2025
Valaris Limited stock logo
VAL
Valaris
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$46.00 ➝ $35.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/AN/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
$2.36B1.37$6.97 per share6.52$31.56 per share1.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/A0.00N/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/A-$0.16N/AN/AN/AN/AN/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/A-$0.07N/AN/AN/AN/AN/A7/25/2025 (Estimated)
Valaris Limited stock logo
VAL
Valaris
$373.40M$4.2610.676.98N/A12.61%14.14%7.06%7/30/2025 (Estimated)

Latest VAL, ATTBF, ABCN, ABZA, and LBTSF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Valaris Limited stock logo
VAL
Valaris
$1.18N/AN/AN/A$582.70 millionN/A
4/30/2025Q1 2025
Valaris Limited stock logo
VAL
Valaris
$1.10-$0.53-$1.63-$0.53$582.87 million$620.70 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/AN/AN/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/AN/AN/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/AN/AN/A
Valaris Limited stock logo
VAL
Valaris
0.49
1.67
1.67

Institutional Ownership

CompanyInstitutional Ownership
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
32.45%
Almirall, S.A. stock logo
LBTSF
Almirall
16.10%
Valaris Limited stock logo
VAL
Valaris
96.74%

Insider Ownership

CompanyInsider Ownership
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/A
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/A
Almirall, S.A. stock logo
LBTSF
Almirall
N/A
Valaris Limited stock logo
VAL
Valaris
0.73%
CompanyEmployeesShares OutstandingFree FloatOptionable
VIVO Cannabis Inc. stock logo
ABCN
VIVO Cannabis
N/A194.41 millionN/ANot Optionable
Abattis Bioceuticals Corp. stock logo
ATTBF
Abattis Bioceuticals
N/AN/AN/ANot Optionable
Almirall, S.A. stock logo
LBTSF
Almirall
1,996N/AN/ANot Optionable
Valaris Limited stock logo
VAL
Valaris
5,64271.07 million70.55 millionOptionable

Recent News About These Companies

Valaris Limited (VAL) - Yahoo Finance
Valaris: Capitalizing On The Multi-Year Offshore Cycle
Valaris (NYSE:VAL) Gains Amid Ratio S&P 500
Valaris: Extracting Value From The Depths

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
VIVO Cannabis stock logo

VIVO Cannabis CVE:ABCN

C$1.32 +0.07 (+5.60%)
As of 08/3/2018

ABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.

Abattis Bioceuticals stock logo

Abattis Bioceuticals OTCMKTS:ATTBF

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Almirall stock logo

Almirall OTCMKTS:LBTSF

$13.36 0.00 (0.00%)
As of 07/3/2025

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Valaris stock logo

Valaris NYSE:VAL

$45.44 +0.01 (+0.02%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$45.47 +0.03 (+0.07%)
As of 07/3/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Valaris Limited, together with its subsidiaries, provides offshore contract drilling services Gulf of Mexico, South America, North Sea, the Middle East, Africa, and the Asia Pacific. The company operates through four segments: Floaters, Jackups, ARO, and Other. It owns an offshore drilling rig fleet, which include drillships, dynamically positioned semisubmersible rigs, moored semisubmersible rig, and jackup rigs. It serves international, government-owned, and independent oil and gas. Valaris Limited was founded in 1975 and is based in Hamilton, Bermuda.